PharmAust Receives Nearly AU$890,000 Tax Rebate

MT NewswiresOct 8 19:09 ET

PharmAust Files Orphan Medicinal Product Designation for Sclerosis Treatment Following Regulatory Guidance

MT NewswiresSep 16 20:14 ET

PharmAust Ltd: Appendix 4E and 2024 Annual Report

Aug 30 02:32 ET · Announcements

PharmAust Raises AU$7.8 Million via Share Placement

MT NewswiresJul 23 22:31 ET

PharmAust (ASX:PAA) Shareholders Have Earned a 21% CAGR Over the Last Five Years

Yahoo FinanceJul 23 18:54 ET

PharmAust Awarded SME Status in Europe, Further Promoting MND Treatment

Small CapsJun 30 21:22 ET